TickerFactsScreenerDevelopers

SANGAMO THERAPEUTICS, INC (SGMO) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $55.40M2009: $71.78M2010: $55.91M2011: $80.13M2012: $64.90M2013: $121.71M2014: $206.63M2015: $192.44M2016: $136.19M2017: $187.90M2018: $366.52M2019: $432.55M2020: $498.23M2021: $375.34M2022: $294.96M2023: $82.89M2024: $22.77M2025: -$14.27M-$14.27M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$14.27M-162.7%
2024$22.77M-72.5%
2023$82.89M-71.9%
2022$294.96M-21.4%
2021$375.34M-24.7%
2020$498.23M+15.2%
2019$432.55M+18.0%
2018$366.52M+95.1%
2017$187.90M+38.0%
2016$136.19M-29.2%
2015$192.44M-6.9%
2014$206.63M+69.8%
2013$121.71M+87.5%
2012$64.90M-19.0%
2011$80.13M+43.3%
2010$55.91M-22.1%
2009$71.78M+29.6%
2008$55.40M—